Dianthus Therapeutics | MGTA - Net Income


Dianthus Therapeutics reported $-64.43M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Akebia Therapeutics USD -12.24M 12.78M Dec/2025
Alaunos Therapeutics USD -1.01M 153K Mar/2026
Avita Medical AUD -11.62M 1.7M Dec/2025
Celltrion KRW 8.88B 322.47B Dec/2025
Cspc Pharmaceutical CNY 370.72M 592.81M Dec/2025
Deva Holding AS TRY 583.98M 319.1M Sep/2023
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Divis Laboratories Ltd INR 7.51B 1.68B Mar/2026
IQVIA Holdings USD 274M 240M Mar/2026
Kangmei Pharma CNY -16.56M 12.74M Mar/2026
Knight Therapeutics CAD -3.79M 8.83M Sep/2025
Laboratorios Farma EUR 103.69M 37.04M Dec/2023
Malin Corporation EUR -1.1M 2.2M Dec/2023
Medical Developments International AUD -226K 121K Dec/2025
Moderna USD -1.34B 517M Mar/2026
Neuren Pharmaceuticals AUD 15.4M 7.88M Dec/2025
Organigram Holdings CAD 19.97M 57.93M Dec/2025
Organon & Co USD -205M 365M Dec/2025
Ovoca Bio EUR -765K 4.89M Jun/2025
Pharma Mar EUR 1.53M 58.13M Mar/2026
Qiagen NV USD 107.83M 22.21M Dec/2025
Revvity USD 40.72M 57.65M Mar/2026
Sartorius EUR 56.2M 37M Mar/2026
Sino Biopharmaceutical CNY 3.39B 2.91B Jun/2025
Tectonic Therapeutic USD -19.23M 186K Dec/2025
Tilray USD -44.93M 44.61M Sep/2025
Viatris USD 176.4M 516.5M Mar/2026
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025
Zealand Pharma A/S -379.12M 25.12M Dec/2025
Zz Pientze Pharmaceu CNY 743.48M 56.45M Mar/2026